Rho Experts Discussing the New FDA Guidance on Data Standards during Free Webinar

CHAPEL HILL, NC, UNITED STATES - Mar 3, 2015 - WHAT:  Rho, a full-service contract research organization (CRO), will provide valuable insight and important considerations for adopting the recent Food and Drug Administration (FDA) Guidance, “Providing Regulatory Submissions in Electronic Format - Standardized Study Data,” through a free webinar. Understanding these guidelines is paramount to the success and efficiency of a trial, as submissions that are not electronic or in the appropriate format will not be filed.

During the webinar, Rho’s Rob Woolson, chief strategist, Biostatistics and Data Standards for Regulatory Submissions, and Ben Vaughn, senior statistical scientist, will review key points in the FDA guidance, followed by a discussion of the implications for sponsors currently conducting studies and those who will be starting new studies soon.                                        

WHO: Rob Woolson and Ben Vaughn                                

WHEN:   Thursday, March 12, 2015

             1:00 p.m. ET/ 10 a.m. PT

              Duration:  60 minutes

Webinar Registration: http://www.fiercepharma.com/offer/rho_march2015?source=Rho

DETAILS: For media inquiries, please contact Bernadette Miller at Largemouth Communications, (703) 297-5992, bernadette@largemouthpr.com.

ABOUT:  Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 31 years, Rho has been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter.